๐๏ธ Verified NIH Record โข Updated 2025-07-21
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease (NCT05205954)
๐ข Recruiting Observational / Diagnostic ๐ง Behavioral & Psychological Program Sponsor: Massachusetts General Hospital
๐ฉบ Plain-English Summary (8th-Grade Level)
This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
Who can join: Review the eligibility criteria below.
Location: Massachusetts General Hospital โ Boston, Massachusetts
Age range: 18 Years
๐งช Interventions in This Study
- Hepatology Home Hospital (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- Massachusetts General Hospital โ Boston, Massachusetts
- Massachusetts General Hospital โ Boston, Massachusetts
๐ Contact the Study Coordinator
Phone: (617) 643-3408
Email: nufere@partners.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cirrhosis
- Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement โ Richmond, Virginia
- Liver Cirrhosis Network Cohort Study โ La Jolla, California
- Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis โ Los Angeles, California
- Oral Health In Cirrhosis of the Liver (ORACLE) โ Richmond, Virginia
- Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis โ Ann Arbor, Michigan
- Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis โ San Francisco, California
Explore by condition: All Cirrhosis clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.